Your browser is no longer supported. Please, upgrade your browser.
Settings
GALE Galena Biopharma, Inc. daily Stock Chart
GALE [NASD]
Galena Biopharma, Inc.
Index- P/E- EPS (ttm)-1.16 Insider Own0.10% Shs Outstand36.29M Perf Week-6.84%
Market Cap21.30M Forward P/E- EPS next Y-0.73 Insider Trans-98.50% Shs Float34.35M Perf Month-8.30%
Income-11.10M PEG- EPS next Q-0.22 Inst Own6.20% Short Float10.02% Perf Quarter-71.78%
Sales- P/S- EPS this Y77.80% Inst Trans30.66% Short Ratio1.24 Perf Half Y-92.07%
Book/sh2.54 P/B0.23 EPS next Y-28.20% ROA-33.80% Target Price8.00 Perf Year-97.23%
Cash/sh0.50 P/C1.18 EPS next 5Y- ROE-110.40% 52W Range0.53 - 49.80 Perf YTD-69.75%
Dividend- P/FCF- EPS past 5Y9.90% ROI- 52W High-98.82% Beta1.58
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low10.74% ATR0.06
Employees14 Current Ratio1.20 Sales Q/Q- Oper. Margin- RSI (14)29.53 Volatility10.57% 9.82%
OptionableYes Debt/Eq0.57 EPS Q/Q87.10% Profit Margin- Rel Volume0.42 Prev Close0.59
ShortableYes LT Debt/Eq0.00 EarningsMar 15 AMC Payout- Avg Volume2.77M Price0.59
Recom3.00 SMA20-7.16% SMA50-44.02% SMA200-92.18% Volume1,162,676 Change-1.06%
Feb-06-17Downgrade FBR & Co. Outperform → Mkt Perform $11 → $4
Feb-02-17Downgrade Maxim Group Buy → Hold
Dec-02-16Reiterated Maxim Group Buy $1 → $4
Aug-10-16Reiterated Maxim Group Buy $2 → $1
Jul-22-16Reiterated FBR Capital Outperform $5 → $2
Jul-11-16Reiterated Maxim Group Buy $4 → $2
Jun-29-16Downgrade Raymond James Outperform → Mkt Perform
Dec-22-15Reiterated Maxim Group Buy $7 → $4
Dec-08-15Upgrade Cantor Fitzgerald Sell → Hold
Nov-12-15Upgrade Oppenheimer Perform → Outperform $4
Nov-10-15Reiterated ROTH Capital Buy $8 → $6
Sep-09-15Initiated Raymond James Outperform
Mar-09-15Reiterated Needham Buy $7 → $4
Nov-20-14Reiterated MLV & Co Buy $3 → $5
Aug-22-14Reiterated MLV & Co Buy $5 → $3.50
Aug-12-14Reiterated Needham Buy $9 → $7
Feb-03-14Reiterated Noble Financial Buy $4 → $6
Jan-21-14Reiterated Maxim Group Buy $9 → $11
Jan-08-14Reiterated Maxim Group Buy $6 → $9
Nov-26-13Initiated Oppenheimer Outperform $6
Mar-24-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Air Methods Corporation, Fortress Investment Group LLC, Galena Biopharma, Inc., Ionis Pharmaceuticals, Inc., LMI Aerospace, Inc., Lumos Networks Corp., Silver Bay Realty Trust Corp. and Terra PR Newswire
Mar-23-17 04:45PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
12:33PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:36AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) and Lead Plaintiff Deadline: April 14, 2017 Accesswire
Mar-21-17 01:04PM  GALENA BIOPHARMA, INC. Financials -6.35%
Mar-20-17 11:04AM  SHAREHOLDR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:34AM  New Strong Buy Stocks for March 20th
09:30AM  Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma Accesswire
Mar-17-17 05:13PM  GALE STOCK LOSS: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action GALE GlobeNewswire
02:03PM  Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Galena Biopharma, Inc. - GALE Accesswire
10:49AM  Galena Ovarian Cancer Drug Reports Positive Data at Investopedia
07:05AM  Galena Biopharma Presents Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data GlobeNewswire
Mar-16-17 12:51PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire +6.90%
10:26AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) and Lead Plaintiff Deadline: April 14, 2017 Accesswire
Mar-15-17 07:25PM  Galena Biopharma reports 4Q loss +5.45%
07:17PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Galena Biopharma, Inc. To Contact The Firm Before Lead Plaintiff Deadline GlobeNewswire
04:18PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:15PM  Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update GlobeNewswire
07:07AM  Q4 2016 Galena Biopharma Inc Earnings Release - After Market Close
Mar-13-17 04:58PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-10-17 10:45AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017 GlobeNewswire
Mar-09-17 07:05AM  Galena Biopharma Engages Canaccord Genuity to Advise on Strategic Alternatives GlobeNewswire
Mar-07-17 11:18AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
09:00AM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. (GALE) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
Mar-06-17 01:43PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-03-17 03:59PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Galena Biopharma, Inc. GALE GlobeNewswire
Mar-02-17 10:26AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) and Lead Plaintiff Deadline: April 14, 2017 Accesswire
Feb-27-17 11:30AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Feb-26-17 06:00PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Feb-24-17 06:00PM  IMPORTANT GALENA BIOPHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the District of New Jersey against Galena Biopharma, Inc. GlobeNewswire +7.81%
Feb-23-17 04:59PM  How to Dig Deep for Value in These Exuberant Markets
02:00PM  Value Investors Have to Go Deeper
12:06PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:25AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) and Lead Plaintiff Deadline: April 14, 2017 Accesswire
Feb-22-17 07:19PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Business Wire -9.72%
12:44PM  Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc. PR Newswire
Feb-21-17 04:25PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
04:10PM  Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer GlobeNewswire
Feb-20-17 06:14PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:17PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
03:29PM  GALE FRAUD NOTICE: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action GALE Business Wire
Feb-16-17 02:09PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Galena Biopharma, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017 GlobeNewswire
Feb-15-17 09:05PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
08:54PM  CORRECTING and REPLACING Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Galena Biopharma, Inc. Business Wire
07:35PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. (GALE) To Contact Brower Piven Before The Lead Plaintiff Deadlin GlobeNewswire
01:11PM  INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
Feb-14-17 06:27PM  Robbins Arroyo LLP: Galena Biopharma, Inc. (GALE) Misled Shareholders According to a Recently Filed Class Action Business Wire
06:16PM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Business Wire
Feb-13-17 04:30PM  Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire +5.41%
12:43PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017 PR Newswire
12:11PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Galena Biopharma, Inc. Investors Business Wire
10:10AM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc. Business Wire
Feb-10-17 05:49PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galena Biopharma, Inc. - GALE PR Newswire -9.76%
05:09PM  Pawar Law Group Announces Investigation of Securities Claims Against Galena Biopharma, Inc. - GALE Accesswire
04:57PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem
04:04PM  Biostage, Fossil Group Tumble into Fridays 52-Week Low Club
01:03PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Galena Biopharma Inc. and Encourages Investors to Contact the Firm Business Wire
12:48PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galena Biopharma, Inc. (GALE) PR Newswire
12:14PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Galena Biopharma, Inc. GALE Business Wire
Feb-09-17 05:06PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Galena Biopharma Inc. and Advises Investors with Losses to Contact the Firm Business Wire
03:40PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Galena Biopharma, Inc. Investors Business Wire
10:15AM  Galena Drops on Discounted $17M Stock Offering at Investopedia
Feb-08-17 04:08PM  Gilead Sciences, Fitbit Plunge into Wednesdays 52-Week Low Club -40.71%
11:35AM  Wednesdays Biggest Biopharma Movers
09:01AM  Galena Biopharma's stock plunges toward record low after stock offering at MarketWatch
08:30AM  Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire
Feb-07-17 04:10PM  Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
04:02PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princip
01:00PM  Galena's Breast Cancer Drug NeuVax Was Deemed Safe at Investopedia
Feb-06-17 11:42AM  Why Galena Biopharma Stock Is Soaring Today at Motley Fool +17.50%
07:30AM  Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns at MarketWatch
07:05AM  Galena Biopharma Reports Positive Outcome from the Data Safety Monitoring Board on the Two NeuVax (nelipepimut-S) Clinical Trials in Combination with Trastuzumab GlobeNewswire
06:28AM  Galena Biopharma downgraded by FBR & Co.
Feb-02-17 08:37AM  Biopharma CEO exits as pain drug marketing probe deepens at bizjournals.com -12.50%
Feb-01-17 03:18PM  Galena CEO Axed Amid Justice Dept Investigation at Investopedia -22.42%
Jan-31-17 06:16PM  Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing
05:00PM  Galena Biopharma Announces the Resignation of its President and Chief Executive Officer and the Evaluation of Strategic Alternatives GlobeNewswire
Jan-25-17 09:45AM  Biotech Industry a Focus in 2017: Latest Reports on Marinus Pharmaceuticals and Galena Biopharma Accesswire
Jan-09-17 04:04PM  DryShips, Stage Stores Plunge into Mondays 52-Week Low Club
07:29AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events
Jan-05-17 07:05AM  Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017 GlobeNewswire
Dec-29-16 01:30PM  Galena Biopharma Pipeline Developments Third Quarter 2016 Results and Outlook Accesswire -13.87%
10:08AM  Galena Biopharma Reveals Regulatory Pathway for GALE-401
Dec-28-16 03:43PM  Galena Rises on FDA Approval +21.43%
09:04AM  Galena Biopharma shares jump 26% after news that drug will enter late-stage trial at MarketWatch
07:05AM  Galena Biopharma Confirms Regulatory Pathway for GALE-401 (Anagrelide Controlled Release) GlobeNewswire
Dec-22-16 05:31PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events -6.25%
11:52AM  Galena Biopharma Stock Has Fallen 93% in 2016 -- Could It Get Any Worse? at Motley Fool
Dec-16-16 10:07PM  Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? at Insider Monkey
Dec-14-16 01:18PM  Is Galena Biopharma Inc (GALE) a Good Stock to Buy? at Insider Monkey -5.71%
07:05AM  Galena Biopharma Announces the Phase 2 Clinical Trial of NeuVax (nelipepimut-S) in Ductal Carcinoma in Situ (DCIS) is Open for Enrollment and Screening Patients GlobeNewswire
Dec-12-16 07:05AM  Galena Biopharma Presented Two Posters at the San Antonio Breast Cancer Symposium GlobeNewswire -13.28%
Dec-05-16 02:39PM  Why You Should (and Shouldn't) Buy Galena Biopharma, Inc. at Motley Fool
08:30AM  Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing PR Newswire
08:30AM  Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing CNW Group
Dec-02-16 08:07AM  New Strong Buy Stocks for December 2nd
Dec-01-16 04:39PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events -10.16%
Nov-30-16 01:31PM  Galena Biopharma to Present Two Posters at the San Antonio Breast Cancer Symposium GlobeNewswire
Galena Biopharma, Inc., a biopharmaceutical company, develops hematology and oncology therapeutics that address unmet medical needs. The company develops GALE-401 (anagrelide controlled release), which completed Phase II clinical trial for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. It also develops NeuVax (nelipepimut-S), which is in Phase IIb clinical trial in combination with trastuzumab for HER2 1+ and 2+ node positive and high-risk node negative breast cancer patients; Phase II clinical trial in combination with trastuzumab for HER2 3+ breast cancer patients; Phase II clinical trial for women with ductal carcinoma in situ of the breast; and Phase II clinical trial for patients with gastric cancer. In addition, the company develops GALE-301 and GALE-302 for ovarian, endometrial, and breast cancers. It has strategic development and commercialization partnership with Dr. Reddy's Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in San Ramon, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hudson Bay Capital Management 10% OwnerFeb 08Sale0.842,363,4411,985,2902,036,559Feb 10 06:16 PM
Dunlap RyanFormer Chief Financial OfficerJun 01Option Exercise1.79126,875227,394145,577Jun 07 06:36 PM
Dunlap RyanFormer Chief Financial OfficerJun 01Sale2.18126,875276,58818,702Jun 07 06:36 PM